ReviewCureus2021

Safety and Efficacy of Risankizumab and Infliximab in the Treatment of Plaque Psoriasis: Results From a Direct and Indirect Meta-Analysis.

Mohammad AlmohidebPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.